Exercise as a Mean to Control Low-Grade Systemic Inflammation

被引:354
作者
Mathur, Neha
Pedersen, Bente Klarlund [1 ]
机构
[1] Univ Copenhagen, CIM, Dept Infect Dis, DK-2100 Copenhagen, Denmark
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
D O I
10.1155/2008/109502
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Chronic noncommunicable diseases (CNCDs), which include cardiovascular disease, some cancers, for example, colon cancer, breast cancer, and type 2 diabetes, are reaching epidemic proportions worldwide. It has now become clear that low-grade chronic inflammation is a key player in the pathogenesis of most CNCDs. Given that regular exercise offers protection against all causes of mortality, primarily by protection against atherosclerosis and insulin resistance, we suggest that exercise may exert some of its beneficial health effects by inducing anti-inflammatory actions. Recently, IL-6 was introduced as the first myokine, defined as a cytokine, which is produced and released by contracting skeletal muscle fibres, exerting its effects in other organs of the body. We suggest that skeletal muscle is an endocrine organ and that myokines may be involved in mediating the beneficial effects against CNCDs associated with low-grade inflammation. Copyright (c) 2008 N. Mathur and B. K. Pedersen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
引用
收藏
页数:6
相关论文
共 81 条
[1]  
Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5
[2]   Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle [J].
Al-Khalili, Lubna ;
Bouzakri, Karim ;
Glund, Stephan ;
Lonnqvist, Fredrik ;
Koistinen, Heikki A. ;
Krook, Anna .
MOLECULAR ENDOCRINOLOGY, 2006, 20 (12) :3364-3375
[3]   Inflammatory process in type 2 diabetes - The role of cytokines [J].
Alexandraki, Krystallenia ;
Piperi, Christina ;
Kalofoutis, Christos ;
Singh, Jaipaul ;
Alaveras, Antonis ;
Kalofoutis, Anastasios .
DIABETES MELLITUS AND ITS COMPLICATIONS: MOLECULAR MECHANISMS, EPIDEMIOLOGY, AND CLINICAL MEDICINE, 2006, 1084 :89-117
[4]   Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro [J].
Bastard, JP ;
Maachi, M ;
Van Nhieu, JT ;
Jardel, C ;
Bruckert, E ;
Grimaldi, A ;
Robert, JJ ;
Capeau, J ;
Hainque, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05) :2084-2089
[5]   Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction [J].
Bennet, AM ;
Prince, JA ;
Fei, GZ ;
Lyrenäs, L ;
Huang, YH ;
Wiman, B ;
Frostegård, J ;
de Faire, U .
ATHEROSCLEROSIS, 2003, 171 (02) :359-367
[6]   Cytokine regulation of skeletal muscle fatty acid metabolism:: effect of interleukin-6 and tumor necrosis factor-α [J].
Bruce, CR ;
Dyck, DJ .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 287 (04) :E616-E621
[7]   Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people [J].
Bruunsgaard, H ;
Ladelund, S ;
Pedersen, AN ;
Schroll, M ;
Jorgensen, T ;
Pedersen, BK .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 132 (01) :24-31
[8]   Physical activity and modulation of systemic low-level inflammation [J].
Bruunsgaard, H .
JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 78 (04) :819-835
[9]   Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression [J].
Bulló, M ;
García-Lorda, P ;
Megias, I ;
Salas-Salvadó, J .
OBESITY RESEARCH, 2003, 11 (04) :525-531
[10]   Interleukin-6 and tumor necrosis factor-α are not increased in patients with Type 2 diabetes:: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness [J].
Carey, AL ;
Bruce, CR ;
Sacchetti, M ;
Anderson, MJ ;
Olsen, DB ;
Saltin, B ;
Hawley, JA ;
Febbraio, MA .
DIABETOLOGIA, 2004, 47 (06) :1029-1037